376 - 400 of 528
Number of results to display per page
AuthorTitleSubjectDatePublication Type
376 Steiner, Andrew M.Oxidative folding of conotoxins: chemical and biological developments to efficiency of production of short, cysteine-rich peptides2013-05dissertation
377 Klein, Brian DonaldPathophysiology associated with a single gene (MASS1) mutation underlying the robust audiogenic seizure phenotype in Frings miceGenetics2003-05dissertation
378 Duke, Melissa SkeltonPatient attitudes and expectations of pharmacist-provided clinical services in clinic-based community pharmacies2010-12thesis
379 Rice, Robert DavidPatterns of signs, symptoms, and cytokines during the engraftment phase of autologous stem cell transplantationAutotransplantation; Stem Cells2010-02-03dissertation
380 Gross, Mary ElizabethPenetration of cefoperazone into the ventricular fluid in patients with non-inflamed meninges1982-06dissertation
381 Robertson, Charles RayPeptide-based therapeutics: engineering galanin for systemic anticonvulsant and anagesic activity2012-05dissertation
382 Spence, Russell AllenPerformance appraisal of decentralized pharmacists1988-06thesis
383 Kim, DonginpH-Sensitive Micelle for multidrug resistant tumorsMicelles; Cancer; Multidrug Resistance2010-05-14dissertation
384 Duke, Victor HPharmaceutical applications of a Pinyon OleoresinTherapeutic Use1961-05dissertation
385 Allen, Kay HislopPharmacist instruction and patient compliance with medication therapyMedication Error; Patient Instruction1974-03thesis
386 Bevans, Tatjana S.Pharmacokinetic and pharmacodynamic implications of inhaled ester-based anesthetic agents2016-08dissertation
387 Lin, Ching-ShanPharmacokinetic study of uterine progesterone retentionPharmacokinetics; Receptors1997-12dissertation
388 Townsend, Paula LynnPharmacokinetics and dosage adjustment of netilmicin in patients with cystic fibrosis1984-06dissertation
389 Millar, Patsy ElizabethThe pharmacokinetics of cefoperazone in premature infants1981-05dissertation
390 Tyler, Linda StoneThe pharmacokinetics of moxalactam in renal failure patients1981-03dissertation
391 Matyunas, Nancy JoThe pharmacokinetics of pirmenol during short term oral dosingPiperidines - Research; Anti-Arrhythmai Agents; Pharmacokinetics; Cardiac Electrophysiology - Treatment; Hemodynamics1983-06dissertation
392 Turkanis, Stuart Allen.Pharmacological and physiological properties of denervated mammalian skeletal muscle.Physiology; Fibrillatory Activity1967-06thesis
393 Kwon, Sun HyungPharmacological approach for inhibition of neointimal hyperplasia associated with arteriovenous hemodialysis graft stenosis2014-08dissertation
394 Garg, PriyankaPharmacology and gating of SLO2.1, an intracellular Na+ activated potassium channel2014-12dissertation
395 Weaver, Lawrence Clayton.The pharmacology of anticonvulsant drug combinations.Pharmacology; Drug Combinations2008-02-01thesis
396 Stockmann, ChrisPharmacometric benchmarking: quantitative methods to assess the predictive performance of population pharmacokinetic modeling programs2016-05dissertation
397 Jones, Jeffrey A.Pharmacy leaders and the entry-level Doctor of PharmacyMinimal Educational Level; Pharmacy Profession1993-06thesis
398 Liu, Chen-Lun.Physicochemical studies basic to cholesterol gallstone formation and dissolution: correlation between cholesterol thermodynamic activity laser light scattering data nucleation times and or dissolution tendencies.Biocmedial Research; Pharmacology1993-06dissertation
399 Engstrom, Fae LouisePhysiological and neurochemical differences between audiogenic and nonaudiogenic seizure miceConvulsions; Water-Electroyte Balance (Physiology)1985-12dissertation
400 Thompson, Marietta Ione BunnPiperacillin pharmacokinetics in patients with chronic renal failurePiperacillin - Research; Clinical trials, Phase III as topic; Kidney Failure, Chronic - Treatment; Renal Elimination; Osmolar Concentration1980-03dissertation
376 - 400 of 528